Cardioxyl Pharmaceuticals' Series C Round

Cardioxyl Pharmaceuticals raised a round of funding on August 20, 2010.

Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and com…

Articles about Cardioxyl Pharmaceuticals' Series C Round: